These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7027751)
21. Relationship between plasma renin activity and urinary catecholamines in various types of hypertension. Horký K; Kopecká J; Greogorová I; Dvoráková J Endokrinologie; 1976 Jul; 67(3):331-42. PubMed ID: 976208 [TBL] [Abstract][Full Text] [Related]
22. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension. Bras H; Ochs HG; Armbruster H; Heintz R Clin Nephrol; 1976 Feb; 5(2):57-60. PubMed ID: 943254 [TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ; Koopmans RP; van Montfrans GA Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [TBL] [Abstract][Full Text] [Related]
24. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure]. Lifshits NL; Kutyrina IM Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461 [TBL] [Abstract][Full Text] [Related]
25. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension]. Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662 [TBL] [Abstract][Full Text] [Related]
26. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. Bauer IH; Reams GP; Wu Z; Lau-Sieckman A J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905 [TBL] [Abstract][Full Text] [Related]
27. Comparisons of body fluid volumes, plasma renin activity, hemodynamics and pressor responsiveness between juvenile and aged patients with essential hypertension. Ishii M; Ohno K Jpn Circ J; 1977 Mar; 41(3):237-46. PubMed ID: 870721 [TBL] [Abstract][Full Text] [Related]
28. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver. Jespersen B Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012 [TBL] [Abstract][Full Text] [Related]
29. Observations of the role of body fluid volumes and plasma renin activity in the management of hypertension. Dorhout Mees EJ; Geyskes GG; Vos J; Boer P Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):335-46. PubMed ID: 1156038 [TBL] [Abstract][Full Text] [Related]
30. Body sodium-blood volume state in nonazotemic diabetes mellitus. Beretta-Piccoli C; Weidmann P Miner Electrolyte Metab; 1982 Jan; 7(1):36-47. PubMed ID: 7169975 [TBL] [Abstract][Full Text] [Related]
31. [Renin-angiotensin-aldosterone system, blood volume, serum uric acid and urinary excretion of prostaglandins and kallikrein in the arterial hypertension induced by pregnancy]. Fiévet P; Agnès E; Hervé MA; de Frémont JF; Carayon A; Andréjak M; Pleskof L; Desailly I; Mimram A; Fournier A Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1210-5. PubMed ID: 6441541 [TBL] [Abstract][Full Text] [Related]
32. Cardiopulmonary blood volume and plasma renin activity in man: preliminary report. London GM; Guérin AP; Laurent S; London AM; Safar ME J Hypertens Suppl; 1985 Dec; 3(3):S121-3. PubMed ID: 2856686 [TBL] [Abstract][Full Text] [Related]
33. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist]. Ocón J; Mora-Macià J; Castellet R; del Río G Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694 [TBL] [Abstract][Full Text] [Related]
34. [Role of the renin-angiotensin system in arterial hypertension with aortic coarctation in young adults]. Lardoux H; Corvol P; Kreft C; Lancelin B; Ménard J; Pauly-Laubry C; Guermonprez JL; Maurice P Arch Mal Coeur Vaiss; 1980; 73(3):246-53. PubMed ID: 6779740 [TBL] [Abstract][Full Text] [Related]
35. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548 [TBL] [Abstract][Full Text] [Related]
36. Sodium sensitivity of blood pressure in hypertensives is not related to sodium, but rather to renin. Krekels MM; van Es PN; Leunissen KM; De Leeuw PW J Hum Hypertens; 1996 Sep; 10 Suppl 3():S127-30. PubMed ID: 8872843 [TBL] [Abstract][Full Text] [Related]
37. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Sharma P; Kumar A; Shrama BC; Sarin SK Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715 [TBL] [Abstract][Full Text] [Related]
38. [Functional relationships between plasma renin activity and hemodynamic indices in essential arterial hypertension]. Maugeri Saccà C; Zoccali C; Cerrai T; Mallamaci F; Delfino D; De Vito M Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2446-52. PubMed ID: 7008811 [TBL] [Abstract][Full Text] [Related]
39. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756 [TBL] [Abstract][Full Text] [Related]
40. Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension. Malatino LS; Bellanuova I; Cataliotti A; Cuzzola F; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Mangiafico RA; Ferri C; Galletti F; Glorioso N; Strazzullo P; Zoccali C J Nephrol; 2000; 13(3):178-84. PubMed ID: 10928293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]